Clinical Trials Logo

Shoulder Joint Disorder clinical trials

View clinical trials related to Shoulder Joint Disorder.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06314321 Completed - Clinical trials for Hemodialysis Complication

The Effect of Baduanjin on Shoulder Function in Maintenance Hemodialysis Patients

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to examine the effect of 18-month Baduanjin exercise on shoulder joint function in maintenance hemodialysis (MHD) patients. 60 MHD patients aged 18-75 will included in this study and randomly divided into two groups (intervention group and control group). The intervention group will be led by a professional person and underwent Baduanjin exercise three times a week before hemodialysis. The control group maintained routine treatment and daily activities.

NCT ID: NCT04777370 Completed - Range of Motion Clinical Trials

Combined Effects of Manual Therapy on the Shoulder

Start date: March 31, 2021
Phase: N/A
Study type: Interventional

Interventions including glenohumeral mobilization, sleeper stretches, and thoracic manipulation have been proposed for individuals with loss of shoulder range of motion (ROM). However, the effect of these interventions on shoulder ROM, joint translation, and muscular activity have not been studied in combination.

NCT ID: NCT04173754 Completed - Clinical trials for Shoulder Joint Disorder

The Effectiveness of MSAT for Patients With ROM Limitation of the Shoulders

Start date: July 4, 2019
Phase:
Study type: Observational [Patient Registry]

This study is a prospective, case-control observational trial. The investigators will compare the MSAT group to the control group to analyze the effectiveness of shoulder MSAT.

NCT ID: NCT03270033 Completed - Pain, Postoperative Clinical Trials

Intravenous Dexmedetomidine, Dexamethasone and Interscalene Block Duration After Arthroscopic Shoulder Surgery

Start date: September 18, 2017
Phase: Phase 4
Study type: Interventional

In this single-centre, double-blinded, randomized controlled superiority trial, 189 participants having outpatient, arthroscopic shoulder surgery will be randomized into 3 equal sized groups. All participants will receive a standardized interscalene brachial plexus block and 4mg of dexamethasone or 50mcg of dexmedetomidine or both intravenously just prior to their surgery. The purpose of this study is to provide a head to head comparison of two types intravenous adjuncts to ISB, corticosteroids and alpha 2 agonists, and determine if their combination, or either one alone provides superior postoperative analgesia in arthroscopic shoulder surgery patients, as well as possibly show a synergistic relationship between the two adjuncts. The investigators hypothesize the combination of adjuncts will provide a longer duration of analgesia compared to either single agent.